At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02659 BAO PHARMA-B
Not Yet Opened 07-15 16:08:33
19.800
-0.180
-0.90%
High20.740
Low19.250
Vol1.30M
Open19.990
D1 Closing19.980
Amplitude7.46%
Mkt Cap6.44B
Tradable Cap3.05B
Total Shares325.00M
T/O26.04M
T/O Rate0.84%
Tradable Shares154.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Bao Pharma Repurchases 100,300 H-Shares for HKD 1.99 Million, Lifting Treasury Stock to 1.04 Million Shares
Shanghai Bao Pharmaceuticals Co Ltd is a China-based company principally engaged in research and development of pharmaceutical products. The Company leverages synthetic biology technology to develop and deliver recombinant biologic drugs, targeting conditions with limited treatment options and complex manufacturing challenges. The Company focuses on four areas, including large-volume subcutaneous drug delivery, antibody-mediated autoimmune conditions, drugs in assisted reproduction and recombinant biologic products as transformative alternative to traditional biochemical production. The Company’s Core Products comprise SJ02 (Slonva), a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP), KJ017, a recombinant human hyaluronidase, and KJ103, an innovative recombinant immunoglobulin G (IgG)-degrading enzyme.